“…Of the 11 isoforms, 3 have been isolated and partially characterized [7,24,26]. Su et al [27] purified and characterized a new immunoreactive isoallergen of Cyn d 1, which will allow for further structural and immunological study, and ultimately for the design of an appropriate therapy.…”